OpenAlex
PricingAboutJobs
Log inGet started
Work

Short-term pre-operative durvalumab (MEDI 4736) in early small triple-negative breast cancer patients (POP-Durva).

HTML

Year: 2025
Type: conference-abstract
Source: Journal of Clinical Oncology
DOI: 10.1200/jco.2025.43.16_suppl.tps623
Authors: Joana M. Ribeiro, Julia Dixon-Douglas, Isabelle Pic, Quentin Blampey, Elie Rassy, Nusaibah Ibrahimi, Marie-Ange Mouret-Reynier, Monica Arnedos, Olivier Tredan, Kamar Serhal, Alessandro A. Viansone, Fernando Bazan, Salim Laghouati, Barbara Pistilli, Magali Lacroix-Triki, Corinne Balleyguier, Maud Kamal, Nadege Bercovici, Paul-Henri Cournede, Fabrice Andre
Institutions: Institut Gustave Roussy, Peter MacCallum Cancer Centre, Supélec, Université Paris-Saclay, CentraleSupélec, Centre Jean Perrin, Institut Bergonié, Centre Léon Bérard, Fondation Gustave Roussy, Centre National de la Recherche Scientifique, Inserm, Université Paris Cité, Institut Cochin
Language: English

Topic: Breast Cancer Treatment Studies
Subfield: Cancer Research
Field: Biochemistry, Genetics and Molecular Biology
Domain: Life Sciences
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W4410818569
Cites:
Cited by:
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms